Terms: = Lung cancer AND ATP2B3, PMCA3, 492, ENSG00000067842 AND Clinical Outcome
1 results:
1. The prognostic landscape of tumor-infiltrating immune cell and immunomodulators in lung cancer.
Liu X; Wu S; Yang Y; Zhao M; Zhu G; Hou Z
Biomed Pharmacother; 2017 Nov; 95():55-61. PubMed ID: 28826097
[TBL] [Abstract] [Full Text] [Related]